A. D. Beadell Investment Counsel, Inc. Gsk PLC Transaction History

A. D. Beadell Investment Counsel, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 19, 2018	SELL	$39.61 - $42.76 $618,708 - $667,911	-15,620 Closed	0 $0
Q1 2018 Apr 25, 2018	SELL	$36.18 - $40.15 $235,170 - $260,975	-6,500 Reduced 29.39%	15,620 $610,000
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $65,202 - $77,305	-1,845 Reduced 7.7%	22,120 $784,000
Q3 2017 Oct 25, 2017	BUY	$39.44 - $41.55 $945,179 - $995,745	23,965	23,965 $972,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78.9B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.